Archives

img-01

CDx Development Slow in China

While the West and Japan are prioritizing personalized medicine and the use of Companion Diagnostics (CDx) to determine which patients will benefit from specific drugs, development in China has been slow. CDx products in China are classified and regulated by existing medical... Read More

img-01

China Cancer Drug Market Growing Quickly

The China cancer drug market is experiencing exponential growth. According to a recent Research and Markets report there are about 5 million cancer patients in China now and by 2027 the market size will be over $35 billion. Cancer is rampant in... Read More

img-01

Indian Clinical Trials Growing Again

Before 2013, there were hundreds of clinical trials done in India that resulted in faulty data, lawsuits, and significant problems. From 2013 to 2019, the number of clinical trials in India dropped significantly. However, in 2019, India implemented New Drug and Clinical... Read More

img-01

Digital Health Growing in Japan

Currently, while digital health is very prevalent in the West, it is still at an infant stage in Japan. However, this is changing now. In 2020, a startup in Japan called Cure Up received regulatory approval for its nicotine addiction treatment. Also,... Read More

img-01

Telemedicine Growing in Asia

While telemedicine is now common in the West, it is also now growing in Asia. Some Asian countries recently outlined new telemedicine regulations. For example, Taiwan’s MOH recently announced draft amendments to their initial telemedicine regulation of 2018. Originally, telemedicine was to... Read More